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Pathophysiology of mercuric chloride-induced acute renal fail-
ure in awake rats. N. Lameire, M. Praet, C. van Peteghem, M.
Waterloos, V. Vanderbiesen. University Hospital, Renal Divi-
sion, Dc Pintelaan, Ghent, Belgium, The Netherlands. The ef-
fect of i.p. injection of mercuric chloride (HgCI2), 4.7 mg/kg, on
renal function was studied in conscious rats. The early and the
late effects on renal function (after 1, 2, 3 and 24 hours) were
studied in control (group 1, N = 7), in saline (group 2, N = 8),
and in 10% glucose (group 3, N 7) drinking rats; the late effects
(after 24 hr) were also studied in 1% bicarbonate-drinking rats
(group 4, N = 12). All animals were killed after 24 hours. Balance
studies were performed before mercuric chloride administration,
a sixfold higher daily diuresis was noted in animals of group 3
compared to group 1. GFR was measured by inulin clearance,
and RBF measured by the microsphere method. Renal tissue lev-
els of mercury were determined by atomic absorption. Evalua-
tion of the renal histology was based on light- and electron-
microscopy (EM) in all groups of animals. The early effects on
GFR (mI/mm . kg) and urinary volume (UV) ( 1/mm . kg) are
summarized in the following table:
a higher diuresis, as previously suggested, or to lower mercuric
tissue levels. (3). The results are compatible with the view that
the intrarenal renin content at the onset of the insult is important
in the maintenance of this renal failure.
Incidence of tubular acidosis in patients with chronic renal fail-
ure. E. Matthijs, N. Lameire, and S. Ringoir. University Hospi-
tal, Renal Division, Dc Pintelaan, Ghent, Belgium, The Nether-
lands. The incidence of tubular acidosis in a nonselected group
of patients with varying creatinine clearance (Ce,) (N = 34) was
explored by combination of the short (6 to 8 hr) oral ammonium
chloride loading test (0.1 mg/kg body wt) and the i.v. sodium
bicarbonate loading test (0.8 molar; 1.5 ml/min, until a plasma
bicarbonate level of 30—32 mEq/liter is reached). The response
was compared with the results obtained in seven normal volun-
teers. Patients were divided in three groups: group I (N = 9)with
a Ccrof 100 to 140 mI/mm, group 2 (N = 14) with a Cr of 20 to 50
mL/min, and group 3 (N 11) with a C, of < 20 mI/mm. Urinary
pH, ammonium (NH4), and titratable acid (TA) were deter-
mined, and T,,, bicarbonate and fractional bicarbonate excretion
Control
24 hr before HgCI2 HgCl2 at 1 hr HgCI2 a
GFR
t 2 hr
UV
HgCl2 at 3 hr
GFR UV GFR UV GFR UV
Group I
Group2
Group3
8.78 0.37 63.4
9.11 0.68 56.5
8.27 0.92 76.7
7.1
5.2
5.1
6.89 0.87
6.23 1.09
3.40 1.10
76.8 26
64.5 15.4
65.1 13.7
4.98 0.80
4.08 1.10
1.79 0.82
76.8
48.4
53.4
20
12
10
3.67 0.74
3.27 1.15
1.75 0.90
78.5 38
48.9 16
40.6 6.5
At 24 hours, all animals of groups 1, 3, and 4 were virtually an-
uric, and their serum creatinine levels were 4.88 0.67, 4.83
1.06, and 6.57 0.27 mgIlOO ml, respectively. Animals of group
2 were oliguric, and their serum creatinine was significantly
lower (2.98 0.14 mg/100 ml). Total RBF significantly dropped
with 44% and 31%, respectively, at 3 and 24 hours in group 1 and
with 37 and 39% in group 3; a marked outer cortical ischemia was
noted. In group 2 a significant fall in RBF of 32% occurred at 3
hours, without redistribution, but no change at 24 hours was
noted with the control animals. Renal tissue mercuric levels at 24
hours were significantly lower in group 2, 90.7 20.9 g for both
kidneys, compared to 198.6 18.1 g in group 1 and 188 32.8
g in group 3. However, no significant difference in mercuric
tissue levels was noted between sodium-chloride-loaded and bi-
carbonate-loaded animals, despite much higher 24-hour serum
creatinine levels in the latter. No difference in renal histology
could be made at either 3 or 24 hours between all groups. Frank
tubular necrosis was present with normal glomeruli at EM exam-
ination. Conclusion. (1). The early phase of this model of acute
renal failure is characterized by intense vasoconstriction, in both
so-called protected (sodium chloride loading) and nonpro-
tected animals (bicarbonate, glucose loading). (2). This protec-
tion in sodium chloride loaded animals is unrelated to either
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(FE110- over a wide range of plasma bicarbonate levels were cal-
culated. The table shows (mean sEM), in each group, for pa-
tients with normal urinary acidification capacity (U,H < 5.45),
the minimum UPH, maximum NH4 and TA excretion after
NH4-loading and FEHc at normal plasma bicarbonate levels.
A distal tubular acidification defect, defined as a U, > 5.45,
after acute induction of systemic acidosis was observed in 2/9
patients in group I, in 1/14 patients in group 2 and in 5/11 patients
in group 3 (an overall incidence of 23.5%). A progressive de-
crease of Tm bicarbonate was noted with progression of the renal
functional impairment. Besides the surprisingly high incidence of
a distal tubular acidification disturbance (type 1) in this group of
renal patients, one case of type IV distal tubular acidosis and two
cases of proximal tubular acidosis (type II) were detected. Since
the adequate treatment of uremic acidosis, associated with an
additional tubular acidosis, requires higher doses of bicarbonate,
it may be useful to include systematic exploration of the tubular
acidification capacity in the elevation of the uremic patient.
Focal segmental glomerular hyalinosis and sclerosis in mem-
branous glomerulopathy. M. S. Schilthuis, J. D. Elema, and G.
K. v.d. Hem. Departments of Pathology and Medicine, Univer-
sity Hospital, Groningen, The Netherlands. To investigate the
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Controls Group I Group 2 Group 3
Mm U,11 5.01 0.079 5.15 0.096 4.93 0.078 5.19 0.180
Max NH4, Eq/min 68.03 6.58 80.74 11.91 37.35 2.74 22.95 8.20
Max TA, zEq/min 35.26 2.90 32.90 4.79 26.67 2.58 17.43 3.21
FE11c, % 0.07 0.02 0.99 0.53 3.15 1.75 4.19 0.98
possibility that focal segmental glomerular hyalinosis and scle-
rosis (FSGHS) represents a nonspecific lesion, kidney biopsies
of 22patients with membranous glomerulopathy (MGP) were re-
viewed by light microscopy for the presence of FSGHS, and its
clinical significance was evaluated. FSGHS was found in 9 out of
28 biopsies with MGP (7 patients, 32%). The presence of these
lesions was often related to more advanced stages of MGP (II
and III). Mean follow-up period for MGP patients without
FSGHS was 51 months; for MGP + FSGHSpatients, 41 months.
The mean age at first clinical signs for the MGP group was 32
years (range, Ito 62 yr); for the MGP + FSGHS group, it was 49
years (range, 30 to 66 yr). This difference achieved no statistical
significance (x2 test,P > 0.2). Likewise, the two groups showed
no differences for sex, presence of proteinuria > 5 g/24 hr, ne-
phrotic syndrome, or microscopic hematuria. Hypertension (dias-
tolic pressure,> 100mm Hg) was present in 71% of patients with
MGP + FSGHS and in 6% of patients with MGP only at first
examination (x2 test, P <0.01). Impaired renal function (GFR, <
90 mI/mm) was present in 71% of patients with MGP + FSGHS
and in 20% of patients wilh MGP only at first biopsy (x2 test,P <
0.02). Mean selectivity index of protein excretion
/ CIgGI— . xlOO%C transferrin
was 26.4% for the MGP + FSGHS group and 17.9% for the
MGP group. Mean GFR of MGP + FSGHS patients had de-
creased from 78 mllmin at first biopsy to 53 mI/mm at last exami-
nation, whereas that of MGP patients had remained stable (110 to
106 mI/mm.). Apparently FSGHS may occur in an idiopathic
form, as well as a superimposed lesion in membranous glomer-
ulopathy. FSGHS probably represents a nonspecific lesion of
unknown pathogenesis. Its presence may indicate a less favour-
able prognosis of the underlying disease.
Autoimmune response against glomerular basement membrane
in inbred rats. M. Stuffers-Heiman, E. Gunther, and L. A. van
Es. Department of Nephrology, University Hospital, Leiden,
The Netherlands, and Department of Immune Biology, Max-
Planck Institut, Freiherg, Germany. The purpose of this study
was to induce a renal autoimmune disease analogous to Good-
pastures syndrome. Previous attempts to induce an autoimmune
response to antigens of the glomerular basement membrane
(GBM) in rats by immunization with heterologous GBM and
complete Freund adjuvan. (CFA) have been complicated by the
development of autologous immune complex nephritis due to the
extreme susceptibility of rats to renal tubular epithelial antigens
present in the immunogen. In this study, contamination of the
GBM preparation by RTE was prevented by using sodium des-
oxycholate for the isolation of GBM. Nine inbred strains of rats,
each with a different H-I major histocompatibility haplotype,
were immunized twice with 5 mg of bovine GBM and CFA. A
marked linear deposition of rat IgG (lgG1 and IgG2a) along the
GBM was found in Brown Norway (BN) rats. The antigenic
specificity of these antibodies was shown by the fixation in vitro
of the eluted antibodies to the GBM and tubular basement mem-
brane (TBM) of normal kidneys. A much weaker and irregular
deposition of host IgG along the GBM was observed in PVG/c,
AS2, AVN, BD V, DA, and F 344 rats. Of these rats, eluates
from the glomeruli of PVG/c, AVN, BD V, and DA rats fixed
very weakly to the GBM of normal kidney, whereas eluates from
AS2 and F 344 rats did not fix to GBM or TBM. No deposition of
host IgG was found in Lewis rats and the eluate did not fix to
normal kidney. Congenic L.BN rats with the BN H-I" haplotype
and a Lewis strain genetic background did not respond. All
strains showed a positive reaction in a radioimmunoassay with
Bo GBM. No anti-GBM autoantibodies could be detected in the
circulation in a radioimmunoassay with BN GBM. The BN
eluate, however, did bind the autoantigen in this assay. This
study shows a genetical predisposition in BN rats to develop
anti-GBM antibodies on immunization with heterologous GBM
and CFA. This genetical predisposition is not, or is not exclu-
sively, linked to the H-I histocompatibility complex.
Diffuse total extracapillary (crescentic) glomerulonephritis with
nonspecific fluorescence pattern (DECGN with nonspecific IFT): a
retrospective study. S. Surachno, A. G. Balk, J. H. ten Veen, S.
S. Wagenaar, and J. M. Wilmink. University Hospital, Wilhel-
mina Gasthuis, Amsterdam, The Netherlands. From 1162 kidney
biopsy specimens, 35 (3%) were selected on the following cri-
teria: minimum of 6 nonhyalinized glomeruli and more than 80%
exclusively extracapillary proliferative (crescentic) changes.
Twenty-five out of 35 patients with DECGN with nonspecific
IFT (male, 18; female, 7; mean age, 51.9 yr; range, 17 to 79 yr)
were studied. Twenty out of 25 patients (80%) showed symptoms
of systemic disease (male, 14; female, 6). Mortality was high, 13/
25 (52%); seven of these deaths were due to infectious compli-
cations during treatment with steroids alone or in combination
with cytotoxic agents. Twelve out of 25 patients survived; 6/12
were on maintenance dialysis, 6/12 had improvement of renal
function. Two cases studied had temporarily spontaneous im-
provement of renal function; both patients had a relapse and
were treated with steroids. One patient died during this treat-
ment of pneumonia; one patient recovered. From this study it
seems that glomerular fibrosis has no prognostic value.
Changes in renal hemodynamics during treatment of essential
hypertension with hydrochlorothiazide. P. van Brummelen, E.
Bussemaker, M. Woerlee and M. A. D. H. Schalekamp. Depart.
of Nephrology, University Hospital, Leiden; Dept. of Biology,
State University, Utrecht; and Dept. of Internal Medicine,
Erasmus University, Rotterdam, The Netherlands. In most pa-
tients with essential hypertension, renal blood flow (RBF) is di-
minished, but GFR is relatively normal. As a consequence, filtra-
tion fraction (FF) and renal vascular resistance (RVR) are in-
creased. These renal abnormalities could play a role in sustaining
elevated arterial pressure. Acute effects of thiazide diuretics in-
clude a decrease in RBF and GFR and an increase in FF and
RVR. Data on the therapeutically more important chronic effects
are scarce. Ten patients with uncomplicated essential hyper-
tension were investigated during placebo and after I week and 3,
6, and 9 months of hydrochlorothiazide (HCT), 100 mg per day.
RBF and GFR were determined simultaneously with a single-
injection clearance technique. At the same time, plasma renin
concentration (PRC) and urinary vanil mandelic acid (VMA)
excretion were measured. Mean arterial pressure was lowered
significantly by HCT (P < 0.01). During the first week of HCT,
RBF decreased (P < 0.05). GFR also decreased, but the dif-
ference was statistically not significant. Hereafter both RBF and
GFR increased progressively to values above pretreatment
levels. FF and RVR increased during the first week of HCT,
followed by a gradual decline. The decrease in RVR was signifi-
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cant after 3. 6, and 9 months of treatment. Both PRC and VMA
increased during the first week of HCT. Subsequently, PRC re-
mained elevated while VMA was lowered significantly as com-
pared with the placebo period. These results confirm the adverse
effect of short-term thiazide treatment on renal function. Pro-
longed treatment, however, is shown to have a beneficial effect
on abnormal renal hemodynamics in essential hypertension. Be-
sides the lowering of the blood pressure per Se, changes in the
renin-angiotensin system and the adrenergic nervous system
may have contributed.
Reversible proximal myopathy in renal osteodystrophy after cal-
ciferol. J. M. Wilmink, J. B. Vuurmans, W. B. J. Hootsmans.
University Hospital, Wilhelmina Gasthuis Amsterdam. Pro-
nounced proximal myopathy is only incidentally reported in pa-
tients with advanced renal failure and renal osteodystrophy. Im-
provement is sometimes observed after therapy with vitamin D.
In the course of severe renal failure due to polycystic disease
(creatinin clearance, 4 mI/mm), proximal myopathy was ob-
served in a 52-yr-old female. In January 1972, neurological ex-
amination, including electromyography, revealed proximal my-
opathy without any sign of uremic neuropathy. Plasma calcium
concentration was normal; plasma phosphate (2.4 mmoles/liter)
and alkaline phosphatase (200 U/liter) were raised. Roentgeno-
grams of the hands showed subperiostal bone resorption, and
bone biopsy revealed ostitis fibrosa. After correction of plasma
phosphate, calciferol treatment (30,000 U/day) was followed by
an impressive improvement of the muscular weakness after some
weeks and complete recovery after 3 months. Thereafter, cal-
ciferol therapy was stopped because of hypercalcemia. In De-
cember 1972, maintenance hemodialysis was started. After 3
years, again proximal myopathy developed. Dihydrotachysterol
therapy (1 mg/day) was started because calciferol therapy was
considered ineffective after bilateral nephrectomy in 1973. Mus-
cular weakness, however, did not show any improvement al-
though hyprercalcemia developed. Calciferol therapy again
promptly induced a complete correction of the muscular weak-
ness. This clinical observation supports the experimental data of
Birge and Haddad that 25-OH cholecalciferol, and cholecalcif-
erol in anephric vitamin-D-deficient rats, correct muscular me-
tabolism; this correction was not observed with renal activated
vitamin D compounds or its analogs.
